332 related articles for article (PubMed ID: 12529448)
41. The caveolin triad: caveolae biogenesis, cholesterol trafficking, and signal transduction.
Schlegel A; Lisanti MP
Cytokine Growth Factor Rev; 2001 Mar; 12(1):41-51. PubMed ID: 11312118
[TBL] [Abstract][Full Text] [Related]
42. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
43. The role of caveolin-1 in PCB77-induced eNOS phosphorylation in human-derived endothelial cells.
Lim EJ; Smart EJ; Toborek M; Hennig B
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3340-7. PubMed ID: 17933968
[TBL] [Abstract][Full Text] [Related]
44. Cell confluence-dependent remodeling of endothelial membranes mediated by cholesterol.
Corvera S; DiBonaventura C; Shpetner HS
J Biol Chem; 2000 Oct; 275(40):31414-21. PubMed ID: 10903311
[TBL] [Abstract][Full Text] [Related]
45. Depletion of plasma membrane cholesterol dampens hydrostatic pressure and shear stress-induced mechanotransduction pathways in osteoblast cultures.
Ferraro JT; Daneshmand M; Bizios R; Rizzo V
Am J Physiol Cell Physiol; 2004 Apr; 286(4):C831-9. PubMed ID: 14644772
[TBL] [Abstract][Full Text] [Related]
46. Cholesterol regulates VEGFR-1 (FLT-1) expression and signaling in acute leukemia cells.
Casalou C; Costa A; Carvalho T; Gomes AL; Zhu Z; Wu Y; Dias S
Mol Cancer Res; 2011 Feb; 9(2):215-24. PubMed ID: 21209384
[TBL] [Abstract][Full Text] [Related]
47. Caveolin-1 is required for signaling and membrane targeting of EphB1 receptor tyrosine kinase.
Vihanto MM; Vindis C; Djonov V; Cerretti DP; Huynh-Do U
J Cell Sci; 2006 Jun; 119(Pt 11):2299-309. PubMed ID: 16723736
[TBL] [Abstract][Full Text] [Related]
48. Hsp90 ensures the transition from the early Ca2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells.
Brouet A; Sonveaux P; Dessy C; Balligand JL; Feron O
J Biol Chem; 2001 Aug; 276(35):32663-9. PubMed ID: 11425855
[TBL] [Abstract][Full Text] [Related]
49. Role of G(i/o)-Src kinase-PI3K/Akt pathway and caveolin-1 in β₂-adrenoceptor coupling to endothelial NO synthase in mouse pulmonary artery.
Banquet S; Delannoy E; Agouni A; Dessy C; Lacomme S; Hubert F; Richard V; Muller B; Leblais V
Cell Signal; 2011 Jul; 23(7):1136-43. PubMed ID: 21385608
[TBL] [Abstract][Full Text] [Related]
50. Epidermal growth factor-stimulated tyrosine phosphorylation of caveolin-1. Enhanced caveolin-1 tyrosine phosphorylation following aberrant epidermal growth factor receptor status.
Kim YN; Wiepz GJ; Guadarrama AG; Bertics PJ
J Biol Chem; 2000 Mar; 275(11):7481-91. PubMed ID: 10713051
[TBL] [Abstract][Full Text] [Related]
51. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
Qi JH; Claesson-Welsh L
Exp Cell Res; 2001 Feb; 263(1):173-82. PubMed ID: 11161716
[TBL] [Abstract][Full Text] [Related]
52. Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites.
Dixelius J; Makinen T; Wirzenius M; Karkkainen MJ; Wernstedt C; Alitalo K; Claesson-Welsh L
J Biol Chem; 2003 Oct; 278(42):40973-9. PubMed ID: 12881528
[TBL] [Abstract][Full Text] [Related]
53. VEGF transiently disrupts gap junctional communication in endothelial cells.
Suarez S; Ballmer-Hofer K
J Cell Sci; 2001 Mar; 114(Pt 6):1229-35. PubMed ID: 11228166
[TBL] [Abstract][Full Text] [Related]
54. Vascular endothelial growth factor acts through novel, pregnancy-enhanced receptor signalling pathways to stimulate endothelial nitric oxide synthase activity in uterine artery endothelial cells.
Grummer MA; Sullivan JA; Magness RR; Bird IM
Biochem J; 2009 Jan; 417(2):501-11. PubMed ID: 18816248
[TBL] [Abstract][Full Text] [Related]
55. Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis.
Mahabeleshwar GH; Feng W; Reddy K; Plow EF; Byzova TV
Circ Res; 2007 Sep; 101(6):570-80. PubMed ID: 17641225
[TBL] [Abstract][Full Text] [Related]
56. IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis.
Meyer RD; Sacks DB; Rahimi N
PLoS One; 2008; 3(12):e3848. PubMed ID: 19050761
[TBL] [Abstract][Full Text] [Related]
57. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants.
Gille H; Kowalski J; Li B; LeCouter J; Moffat B; Zioncheck TF; Pelletier N; Ferrara N
J Biol Chem; 2001 Feb; 276(5):3222-30. PubMed ID: 11058584
[TBL] [Abstract][Full Text] [Related]
58. Heterotrimeric G alpha q/G alpha 11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling.
Zeng H; Zhao D; Yang S; Datta K; Mukhopadhyay D
J Biol Chem; 2003 Jun; 278(23):20738-45. PubMed ID: 12670961
[TBL] [Abstract][Full Text] [Related]
59. Phosphorylation of tyrosine 801 of vascular endothelial growth factor receptor-2 is necessary for Akt-dependent endothelial nitric-oxide synthase activation and nitric oxide release from endothelial cells.
Blanes MG; Oubaha M; Rautureau Y; Gratton JP
J Biol Chem; 2007 Apr; 282(14):10660-9. PubMed ID: 17303569
[TBL] [Abstract][Full Text] [Related]
60. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells.
Feng Y; Venema VJ; Venema RC; Tsai N; Caldwell RB
Biochem Biophys Res Commun; 1999 Mar; 256(1):192-7. PubMed ID: 10066445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
